Viewing Study NCT06663059


Ignite Creation Date: 2025-12-24 @ 2:30 PM
Ignite Modification Date: 2025-12-27 @ 8:48 AM
Study NCT ID: NCT06663059
Status: RECRUITING
Last Update Posted: 2024-10-29
First Post: 2024-08-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study
Sponsor: Tang-Du Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module